Skip to content
Subscriber Only

J&J Unit Ordered to Pay $8 Billion Over Anti-Psychotic Drug

  • Jury found company wrongfully marketed Risperdal to teens
  • Award is four times bigger than next-largest 2019 U.S. verdict
Updated on

Johnson & Johnson’s Janssen unit was hit with an $8 billion punitive-damages verdict -- the largest jury award in the U.S. this year -- over its alleged mishandling of an anti-psychotic drug blamed for causing adolescent boys to grow female-sized breasts.

A state court jury in Philadelphia Tuesday concluded the Janssen’s wrongful marketing of its Risperdal drug to teens warranted the punishment award in the first Pennsylvania case in which such damages could be awarded under an appellate ruling.